The role of cost-effectiveness analysis in developing nutrition policy

Annual Review of Nutrition

Volumn 33, Issue , 2013, Pages 373-393

  Cobiac, Linda J ^a   Veerman, Lennert ^a   Vos, Theo ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cost effectiveness; Diet; Primary prevention

Indexed keywords

SODIUM CHLORIDE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; COUNSELING; DECISION TREE; DIET; ECONOMIC ASPECT; FOOD AVAILABILITY; FOOD INTAKE; FOOD PROCESSING; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HIGH RISK POPULATION; HUMAN; MARKETING; MONTE CARLO METHOD; NUTRITION; PRIMARY PREVENTION; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL (TOPIC); SALT INTAKE; WORLD HEALTH ORGANIZATION;

BIOMEDICAL RESEARCH; COST-BENEFIT ANALYSIS; DIET; FOOD SUPPLY; FOOD-PROCESSING INDUSTRY; HEALTH CARE COSTS; HEALTH IMPACT ASSESSMENT; HUMANS; MODELS, ECONOMIC; NUTRITION DISORDERS; NUTRITION POLICY; QUALITY-ADJUSTED LIFE YEARS; RESEARCH DESIGN;

EID: 84880685711     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071812-161133     Document Type: Article

References (120)

1. Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, et al. 2011. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int. J. Epidemiol. 40:985-96
2. Ackermann RT, Marrero DG, Hicks KA, Hoerger TJ, Sorensen S, et al. 2006. An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetes. Diabetes Care 29:1237-41
3. Anderson P, Chisholm D, Fuhr DC. 2009. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 373:2234-46
4. Andreyeva T, Long MW, Brownell KD. 2010. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am. J. Public Health 100:216-22
5. Aschemann-Witzel J, Perez-Cueto FJ, Niedzwiedzka B, VerbekeW, Bech-Larsen T. 2012. Lessons for public health campaigns from analysing commercial food marketing success factors: a case study. BMC Public Health 12:139
6. Astrup A, Grunwald GK, Melanson EL, Saris WH, Hill JO. 2000. The role of low-fat diets in body weight control: a meta-analysis of ad libitum dietary intervention studies. Int. J. Obes. 24:1545-52
7. Baltussen R, Adam T, Tan-Torres Edejer T, Hutubessy R, Acharya A, et al. 2003. Methods for generalized cost-effectiveness analysis. In Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis, ed. T Tan-Torres Edejer, R Baltussen, T Adam, R Hutubessy, A Acharya, DB Evans, CJL Murray, pp. 3-106. Geneva: World Health Organ.
8. Barton GR, Goodall M, Bower P, Woolf S, Capewell S, Gabbay MB. 2011. Increasing heart-health lifestyles in deprived communities: economic evaluation of lay health trainers. J. Eval. Clin. Pract. 18:835-40
9. Bell C, Urbach D, Ray J, Bayoumi A, Rosen A, et al. 2006. Bias in published cost effectiveness studies: systematic review. Br. Med. J. 332:699-703
10. Bentley TG, Weinstein MC, Willett WC, Kuntz KM. 2009. A cost-effectiveness analysis of folic acid fortification policy in the United States. Public Health Nutr. 12:455-67
11. Bertram MY, Lim SS, Barendregt JJ, Vos T. 2010. Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care. Diabetologia 53:875-81
12. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, et al. 2010. Projected effect of dietary salt reductions on future cardiovascular disease. N. Engl. J. Med. 362:590-99
13. Bloom DE, Cafiero ET, Jane-Llopis E, Abrahams-Gessel S, Bloom LR, et al. 2011. The Global Economic Burden of Noncommunicable Diseases. Geneva:World Econ. Forum
14. Brennan A, Chick S, Davies R. 2006. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 15:1295-310
15. Briggs A, Claxton K, Sculpher M. 2006. Decision Modelling for Health Economic Evaluation. New York: Oxford Univ. Press
16. Briggs A, Sculpher M. 1998. An introduction to Markov modelling for economic evaluation. PharmacoEconomics 13:397-409
17. Cairns G, Angus K, Hastings G. 2009. The Extent, Nature and Effects of Food Promotion to Children: A Review of the Evidence to December 2008. Geneva:World Health Organ.
18. Cairns J. 2001. Discounting in economic evaluation. In Economic Evaluation in Health Care: Merging Theory with Practice, ed. M Drummond, A McGuire, pp. 236-55. New York: Oxford Univ. Press
19. Cecchini M, Sassi F, Lauer JA, Lee YY, Guajardo-Barron V, Chisholm D. 2010. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 376:1775-84
20. Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. 2012. Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS ONE 7:e41842
21. Cobiac LJ, Vos T, Doran C, Wallace A. 2009. Cost-effectiveness of interventions to prevent alcoholrelated disease and injury in Australia. Addiction 104:1646-55
22. Cobiac LJ, Vos T, Veerman JL. 2010. Cost-effectiveness of interventions to promote fruit and vegetable consumption. PLoS ONE 5:e14148
23. Cobiac LJ, Vos T, Veerman JL. 2010. Cost-effectiveness of interventions to reduce dietary salt intake. Heart 96:1920-25
24. Cobiac LJ, Vos T, Veerman JL. 2010. Cost-effectiveness of Weight Watchers and the Lighten Up to a Healthy Lifestyle program. Aust. N. Z. J. Public Health 34:240-47
25. Colagiuri S, Walker AE. 2008. Using an economic model of diabetes to evaluate prevention and care strategies in Australia. Health Aff. (Millwood) 27:256-68
26. Dalziel K, Segal L. 2007. Time to give nutrition interventions a higher profile: cost-effectiveness of 10 nutrition interventions. Health Promot. Int. 22:271-83
27. Dalziel K, Segal L, Katz R. 2010. Cost-effectiveness of mandatory folate fortification v. other options for the prevention of neural tube defects: results from Australia and New Zealand. Public Health Nutr. 13:566-78
28. Dansinger ML, Tatsioni A, Wong JB, Chung M, Balk EM. 2007. Meta-analysis: the effect of dietary counseling for weight loss. Ann. Intern. Med. 147:41-50
29. Diabetes Prev. Program Res. Group. 2003. Within-trial cost-effectiveness of lifestyle intervention or metformin for the primary prevention of type 2 diabetes. Diabetes Care 26:2518-23
30. Dodhia H, Phillips K, ZannouMI, AiroldiM, BevanG. 2012. Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population. J. Hypertens. 30:217-26
31. Drummond M, Sculpher M, Torrance G, O?Brien B, Stoddart G, eds. 2005. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford Univ. Press
32. Eddy DM, Schlessinger L, Kahn R. 2005. Clinical outcomes and cost-effectiveness of strategies for managing people at high risk for diabetes. Ann. Intern. Med. 143:251-64
33. Eriksson MK, Hagberg L, Lindholm L, Malmgren-Olsson E-B, Osterlind J, Eliasson M. 2010. Quality of life and cost-effectiveness of a 3-year trial of lifestyle intervention in primary health care. Arch. Intern. Med. 170:1470-79
34. Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. 2011. Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab. Syndr. Relat. Disord. 9:1-12
35. Eussen SR, Feenstra TL, Toxopeus IB, Hoekstra J, Klungel OH, et al. 2011. Costs and health effects of adding functional foods containing phytosterols/-stanols to statin therapy in the prevention of cardiovascular disease. Eur. J. Pharmacol. 668(Suppl. 1):S91-100
36. ForsterM, Veerman JL, Barendregt JJ, Vos T. 2011. Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity. Int. J. Obes. 35:1071-78
37. FreemantleN, Mason J. 1997. Publication bias in clinical trials and economic analyses. PharmacoEconomics 12:10-16
38. Galani C, Schneider H, Rutten FF. 2007. Modelling the lifetime costs and health effects of lifestyle intervention in the prevention and treatment of obesity in Switzerland. Int. J. Public Health 52:372-82
39. George B, Harris A, Mitchell A. 2001. Cost-effectiveness analysis and the consistency of decisionmaking: evidence from pharmaceutical reimbursement in Australia (1991 to 1996). PharmacoEconomics 19:1103-9
40. GilliesCL, Lambert PC, Abrams KR, Sutton AJ, CooperNJ, et al. 2008. Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis. BMJ 336:1180-85
41. Godlee F. 1996. The food industry fights for salt. BMJ 312:1239-40
42. Gold M, Siegel J, Russell L, WeinsteinM, eds. 1996. Cost-Effectiveness in Health and Medicine.New York: Oxford Univ. Press
43. Graves N, Barnett AG, Halton KA, Veerman JL, WinklerE, et al. 2009. Cost-effectiveness of a telephonedelivered intervention for physical activity and diet. PLoS ONE 4:e7135
44. Grosse SD. 2008. Assessing cost-effectiveness in healthcare: history of the $50,000 perQALY threshold. Expert Rev. Pharmacoecon. Outcomes Res. 8:165-78
45. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. 2008. Economic evaluation of a neural tube defect recurrence-prevention program. Am. J. Prev. Med. 35:572-77
46. Ha DA, Chisholm D. 2011. Cost-effectiveness analysis of interventions to prevent cardiovascular disease in Vietnam. Health Policy Plann. 26:210-22
47. Harris J, Felix L, Miners A, Murray E, Michie S, et al. 2011. Adaptive e-learning to improve dietary behaviour: a systematic review and cost-effectiveness analysis. Health Technol. Assess. 15:1-160
48. Henriksen L. 2012. Comprehensive tobacco marketing restrictions: promotion, packaging, price and place. Tob. Control 21:147-53
49. HermanWH, Hoerger TJ, Brandle M, HicksK, Sorensen S, et al. 2005. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann. Intern. Med. 142:323-32
50. Hillman A, Eisenberg J, Pauly M, Bloom M, Glick H, et al. 1991. Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. N. Engl. J. Med. 324:1362-65
51. Hoerger TJ, Hicks KA, Sorensen SW, Herman WH, Ratner RE, et al. 2007. Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults. Diabetes Care 30:2874-79
52. Hurley SF, Matthews JP. 2008. Cost-effectiveness of the Australian National Tobacco Campaign. Tob. Control 17:379-84
53. Jacobs N, Evers S, Ament A, ClaesN. 2010. Cost-utility of a cardiovascular prevention program in highly educated adults: intermediate results of a randomized controlled trial. Int. J. Technol. Assess. Health Care 26:11-19
54. Jacobs-van der Bruggen MA, Bos G, Bemelmans WJ, Hoogenveen RT, Vijgen SM, Baan CA. 2007. Lifestyle interventions are cost-effective in people with different levels of diabetes risk: results from a modeling study. Diabetes Care 30:128-34
55. Jentink J, van de Vrie-Hoekstra NW, de Jong-van den Berg LT, PostmaMJ. 2008. Economic evaluation of folic acid food fortification in The Netherlands. Eur. J. Public Health 18:270-4
56. Kristiansen IS, Eggen AE, Thelle DS. 1991. Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: Is individual intervention worth while? BMJ 302:1119-22
57. Laatikainen T, Pietinen P, Valsta L, Sundvall J, Reinivuo H, Tuomilehto J. 2006. Sodium in the Finnish diet: 20-year trends in urinary sodium excretion among the adult population. Eur. J. Clin.Nutr. 60:965-70
58. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. 2013. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2224-60
59. Lin J, O?Connor E, Whitlock E, Beil T, Zuber S, et al. 2010. Behavioral Counseling to Promote Physical Activity and a Healthful Diet to Prevent Cardiovascular Disease in Adults: Update of the Evidence for the U.S. Preventive Services Task Force. Rockville, MD: Agency Healthc. Res. Qual.
60. Lindgren P, Fahlstadius P, Hellenius M-L, Jonsson B, de Faire U. 2003. Cost-effectiveness of primary prevention of coronary heart disease through risk factor intervention in 60-year-old men from the county of Stockholm-a stochastic model of exercise and dietary advice. Prev. Med. 36:403-9
61. Lindgren P, Lindstrom J, Tuomilehto J, Uusitupa M, Peltonen M, et al. 2007. Lifestyle intervention to prevent diabetes in men and women with impaired glucose tolerance is cost-effective. Int. J. Technol. Assess. Health Care 23:177-83
62. Llanos A, Hertrampf E, Cortes F, Pardo A, Grosse SD, Uauy R. 2007. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 83:295-303
63. Macdiarmid JI, Loe J, Douglas F, Ludbrook A, Comerford C, McNeill G. 2011. Developing a timeline for evaluating public health nutrition policy interventions. What are the outcomes and when should we expect to see them? Public Health Nutr. 14:729-39
64. Magnus A, Haby MM, Carter R, Swinburn B. 2009. The cost-effectiveness of removing television advertising of high-fat and/or high-sugar food and beverages to Australian children. Int. J. Obes. 33: 1094-102
65. Main C, Thomas S, Ogilvie D, StirkL, Petticrew M, et al. 2008. Population tobacco control interventions and their effects on social inequalities in smoking: placing an equity lens on existing systematic reviews. BMC Public Health 8:178
66. Manning W, Fryback D, Weinstein M. 1996. Reflecting uncertainty in cost-effectiveness analyses. In Cost-Effectiveness in Health and Medicine, ed. M Gold, J Siegel, L Russell, M Weinstein, pp. 247-75. New York: Oxford Univ. Press
67. Martikainen JA, Ottelin A-M, Kiviniemi V, Gylling H. 2007. Plant stanol esters are potentially costeffective in the prevention of coronary heart disease in men: Bayesian modelling approach. Eur. J. Cardiovasc. Prev. Rehabil. 14:265-72
68. Martikainen JA, Soini EJ, LaaksonenDE, Niskanen L. 2011. Health economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studies. Eur. J. Clin. Nutr. 65:1148-55
69. McCabe C, Claxton K, Culyer AJ. 2008. The NICE cost-effectiveness threshold: what it is and what that means. PharmacoEconomics 26:733-44
70. McConnon A, Kirk S, Cockroft J, Harvey E, Greenwood D, et al. 2007. The Internet for weight control in an obese sample: results of a randomised controlled trial. BMC Health Serv. Res. 7:206
71. Millett C, Laverty AA, Stylianou N, Bibbins-Domingo K, Pape UJ. 2012. Impacts of a national strategy to reduce population salt intake in England: serial cross sectional study. PLoS ONE 7:e29836
72. Moodie M, Haby M, Galvin L, Swinburn B, Carter R. 2009. Cost-effectiveness of active transport for primary school children-Walking School Bus program. Int. J. Behav. Nutr. Phys. Act. 6:63
73. MoodieM, HabyM, WakeM, GoldL, CarterR. 2008. Cost-effectiveness of a family-based GP-mediated intervention targeting overweight and moderately obese children. Econ. Hum. Biol. 6:363-76
74. Mozaffarian D, Afshin A, Benowitz NL, Bittner V, Daniels SR, et al. 2012. Population approaches to improve diet, physical activity, and smoking habits. Circulation 126:1514-63
75. Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, TomijimaN, et al. 2003. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular- disease risk. Lancet 361:717-25
76. Nghiem N, Wilson N, Blakely T, NZACE Prev. Team. 2011. Price elasticities for health economicmodelling of food pricing interventions in Australia and New Zealand. Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme. Tech. Rep. No. 9, Dep. Public Health, Univ. Otago, Wellington, NZ
77. Nnoaham KE, Sacks G, Rayner M, Mytton O, Gray A. 2009. Modelling income group differences in the health and economic impacts of targeted food taxes and subsidies. Int. J. Epidemiol. 38:1324-33
78. Postma MJ, Londeman J, Veenstra M, de Walle HE, de Jong-van den Berg LT. 2002. Cost-effectiveness of periconceptional supplementation of folic acid. Pharm. World Sci. 24:8-11
79. Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, et al. 2000. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann. Intern.Med. 132:769-79
80. Ranson MK, Jha P, Chaloupka FJ, Nguyen SN. 2002. Global and regional estimates of the effectiveness and cost-effectiveness of price increases and other tobacco control policies. Nicotine Tob. Res. 4:311-19
81. Rappange DR, van Baal PH, van Exel NJ, Feenstra TL, Rutten FF, Brouwer WB. 2008. Unrelated medical costs in life-years gained: Should they be included in economic evaluations of healthcare interventions? PharmacoEconomics 26:815-30
82. Rose G. 1985. Sick individuals and sick populations. Int. J. Epidemiol. 14:32-38
83. Roux L, Kuntz KM, Donaldson C, Goldie SJ. 2006. Economic evaluation of weight loss interventions in overweight and obese women. Obesity 14:1093-106
84. Rubinstein A, Colantonio L, Bardach A, Caporale J, Marti S, et al. 2010. Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina. BMC Public Health 10:627
85. Sacks G, Veerman JL, MoodieM, Swinburn B. 2010. "Traffic-light" nutrition labelling and "junk-food" tax: a modelled comparison of cost-effectiveness for obesity prevention. Int. J. Obes. 7:1001-9
86. Salkeld G, Phongsavan P, Oldenburg B, Johannesson M, Convery P, et al. 1997. The cost-effectiveness of a cardiovascular risk reduction program in general practice. Health Policy 41:105-19
87. Salomon JA, Vos T, Hogan DR, Gagnon M, Naghavi M, et al. 2012. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 380:2129-43
88. Savica V, Bellinghieri G, Kopple JD. 2010. The effect of nutrition on blood pressure. Annu. Rev. Nutr. 30:365-401
89. Shiell A, Hawe P, Perry R, Matthias S. 2009. How health managers think about risk and the implications for portfolio theory in health systems. Health Risk Soc. 11:71-85
90. Smith KJ, Hsu HE, Roberts MS, Kramer MK, Orchard TJ, et al. 2010. Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007. Prev. Chronic Dis. 7:A109 (Abstr.
91. Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM. 2010. Population strategies to decrease sodium intake and the burden of cardiovascular disease. Ann. Intern. Med. 152:481-87
92. Stafford N. 2012. Denmark cancels "fat tax" and shelves "sugar tax" because of threat of job losses. BMJ 345:e7889
93. Straub N, Grunert P, von Kries R, Koletzko B. 2011. Health economic potential of early nutrition programming: a model calculation of long-term reduction in blood pressure and related morbidity costs by use of long-chain polyunsaturated fatty acid-supplemented formula. Am. J. Clin. Nutr. 94:2030-35S
94. Stuckler D, McKeeM, Ebrahim S, Basu S. 2012. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med. 9:e1001235
95. Stuckler D, Nestle M. 2012. Big Food, food systems, and global health. PLoS Med. 9:e1001242
96. Swinburn B. 2008. Obesity prevention: the role of policies, laws and regulations. Aust. N. Z. Health Policy 5:12
97. Swinburn B, Gill T, Kumanyika S. 2005. Obesity prevention: a proposed framework for translating evidence into action. Obes. Rev. 6:23-33
98. Swinburn BA, SacksG, Hall KD, McPherson K, Finegood DT, et al. 2011. The global obesity pandemic: shaped by global drivers and local environments. Lancet 378:804-14
99. te Velde SJ, Lennert Veerman J, Tak NI, Bosmans JE, Klepp KI, Brug J. 2011. Modeling the long term health outcomes and cost-effectiveness of two interventions promoting fruit and vegetable intake among schoolchildren. Econ. Hum. Biol. 9:14-22
100. Thomas D, Elliott E, Baur L. 2007. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst. Rev. 3:CD005105
101. Thow AM, Jan S, Leeder S, Swinburn B. 2010. The effect of fiscal policy on diet, obesity and chronic disease: a systematic review. Bull. World Health Organ. 88:609-14
102. Tiffin R, Salois M. 2012. Inequalities in diet and nutrition. Proc. Nutr. Soc. 71:105-11
103. Tobias M, Blakely T, Matheson D, Rasanathan K, Atkinson J. 2009. Changing trends in indigenous inequalities in mortality: lessons from New Zealand. Int. J. Epidemiol. 38:1711-22
104. Tosteson AN, WeinsteinMC, HuninkMG, MittlemanMA, WilliamsLW, et al. 1997. Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels. Circulation 95:24-30
105. Trueman P, Haynes SM, Felicity Lyons G, Louise McCombie E, McQuiggMS, et al. 2010. Long-term cost-effectiveness of weight management in primary care. Int. J. Clin. Pract. 64:775-83
106. van Baal PH, van den BergM, Hoogenveen RT, Vijgen SM, Engelfriet PM. 2008. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases. Value Health 11:1033-40
107. van Baal PH, Brouwer WB, Hoogenveen RT, Feenstra TL. 2007. Increasing tobacco taxes: a cheap tool to increase public health. Health Policy 82:142-52
108. van Keulen HM, Bosmans JE, van Tulder MW, Severens JL, de Vries H, et al. 2010. Cost-effectiveness of tailored print communication, telephone motivational interviewing, and a combination of the two: results of an economic evaluation alongside the Vitalum randomized controlled trial. Int. J. Behav. Nutr. Phys. Act. 7:64
109. VlismasK, Stavrinos V, Panagiotakos DB. 2009. Socio-economic status, dietary habits and health-related outcomes in various parts of the world: a review. Cent. Eur. J. Public Health 17:55-63
110. Vos T, Barker B, Begg S, Stanley L, Lopez AD. 2008. Burden of disease and injury in Aboriginal and Torres Strait Islander Peoples: the Indigenous health gap. Int. J. Epidemiol. 38:470-77
111. Vos T, Carter R, Barendregt J, Mihalopoulos C, Veerman J, et al. 2010. Assessing Cost-Effectiveness in Prevention (ACE-Prevention). Final Report, Univ. Qld., Brisb./Deakin Univ., Melbourne, Aust.
112. Wang LY, YangQ, Lowry R, Wechsler H. 2003. Economic analysis of a school-based obesity prevention program. Obes. Res. 11:1313-24
113. WHO. 2004. Global Strategy on Diet, Physical Activity and Health. Geneva: World Health Organ. http://www.who.int/dietphysicalactivity/strategy/eb11344/ strategy-english-web.pdf
114. WHO. 2005. CHOosing Interventions That Are Cost Effective (WHO-CHOICE). Cost-Effectiveness Thresholds. Geneva: World Health Organ. http://www.who.int/ choice/costs/CER-thresholds/en/index.html
115. WHO. 2011. Global Status Report on Noncommunicable Diseases 2010. Geneva: World Health Organ. http://www.who.int/nmh/publications/ncd-report-full-en.pdf
116. Wong MD, Shapiro MF, John Boscardin W, Ettner SL. 2002. Contribution of major diseases to disparities in mortality. N. Engl. J. Med. 347:1585-92
117. World Bank. 2006. Repositioning Nutrition as Central to Development: A Strategy for Large-Scale Action. Washington, DC: World Bank. http://siteresources.worldbank.org/NUTRITION/Resources/281846-1131636806329/ NutritionStrategy.pdf
118. World Bank. 2012. GDP Per Capita (Current US$). Washington, DC: World Bank. http://data. worldbank.org/indicator/NY.GDP.PCAP.CD
119. World Bank. 2012. PPP Conversion Factor, GDP (LCU per International $). Washington, DC: World Bank. http://data.worldbank.org/indicator/PA. NUS.PPP
120. World Cancer Res. Fund, Am. Inst. Cancer Res. 2007. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: Am. Inst. Cancer Res. http://eprints.ucl.ac.uk/4841/1/4841.pdf